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Maternal immune activation (MIA)
A B S T R A C T
Disturbances in fetal neurodevelopment have extensively been related to neurodevelopmental disorders in early
and later life. Fetal neurodevelopment is dependent on adequate functioning of the fetal immune system. During
pregnancy, the maternal immune system is challenged to both tolerate the semi-allogenic fetus and to protect the
mother and fetus from microbes. The fetal immune system is inﬂuenced by maternal immune disturbances;
therefore, perturbations in maternal immunity likely do not only alter pregnancy outcome but also alter fetal
neurodevelopment. A possible common pathway could be modulating the functioning of tissue macrophages in
the placenta and brain.
Maternal immune tolerance towards the fetus involves several complex adaptations. In this active maternal
immune state, the fetus develops its own immunity. As cytokines and other players of the immune system -which
can pass the placenta- are involved in neurodevelopment, disruptions in immune balance inﬂuence fetal neu-
rodevelopment. Several studies reported an association between maternal immune activation, complications of
pregnancy as preeclampsia, and altered neonatal neurodevelopment. A possible pathway involves dysfunc-
tioning of microglia cells, the immune cells of the brain. Functionality of microglia cells during normal preg-
nancy is, however, poorly understood. The recent outbreak of ZIKA virus (ZKV), but also the literature on virus
infections in general and its consequences on microglial cell function and fetal neurodevelopment show the
devastating eﬀects a virus infection during pregnancy can have.
1. Introduction
Appropriate neurodevelopment is dependent on adequate and
timely functioning of fetal immune cells within the central nervous
system (CNS). Ample evidence suggests that an appropriate interaction
between the maternal and fetal immune systems inﬂuences embryonic
and fetal neuroimmunology, fetal neurodevelopment, and thereby
postnatal neurodevelopment and cognitive function.
During pregnancy, the maternal immune system is carefully regu-
lated to tolerate the semi-allogeneic fetus. Factors known to inﬂuence
the maternal immune response during pregnancy are direct factors as
infections and environmental circumstances (smoking, nutrition,
stress), characteristics of the mother such as obesity, and speciﬁc
pregnancy related pathology as pre-eclampsia and placental
insuﬃciency. Collectively, these factors occur frequently in pregnant
women and they have been extensively linked to neurodevelopmental
disorders. For example, maternal viral infection during pregnancy has
been implicated in the occurrence of neurodevelopmental problems
(Atladottir et al., 2009; Patterson, 2009; Atladottir et al., 2010; Brown
et al., 2014; Lee et al., 2015). Similarly, systemic inﬂammatory re-
sponses related to preeclampsia (Walker et al., 2015) or related to
maternal body mass index (Gardner et al., 2015) have also been im-
plicated in abnormal neurodevelopment.
The resident immune cells of CNS are microglia, which besides their
roles in tissue inﬂammation and clearance of debris are key players in
the orchestration of synaptic connections. Speciﬁcally, they are in-
volved in removing faulty and unnecessary synapses, and this synaptic
pruning is relevant both during fetal development (Paolicelli et al.,
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2011) and in postnatal life (Schafer et al., 2012). Their role in pruning
and synaptic network formation is more prevalent during late gestation
and early postnatal development, whereas the immune function of
microglia -their CNS macrophage phenotype- is acquired later during
life (Matcovitch-Natan et al., 2016). As a result, microglia dysfunc-
tioning has been suggested to contribute to neurodevelopmental dis-
orders including schizophrenia (Matcovitch-Natan et al., 2016; Sekar
et al., 2016) and autism spectrum disorder (ASD, reviewed in Koyama
and Ikegaya (2015)). The exact mechanisms and maternal-fetal inter-
actions contributing to neurodevelopment are unclear.
2. Methods
A literature search was performed in PubMed for the published
literature on immunology during pregnancy, fetal immune priming,
neuro development, microglia, macrophages, and neuro-immunity.
Relevant articles were identiﬁed by searching for keywords as; immune
system, fetal programming, fetal immune programming, fetal im-
munity, immune function, placenta, priming, neurodevelopment(al),
neuro-immune, preeclampsia, and pregnancy. Additional studies were
identiﬁed by the analysis of reference lists. Data from these studies were
analyzed, interpreted and were presented in this review.
3. Results
3.1. The maternal immune system during pregnancy is well orchestrated to
optimize pregnancy outcome
The exact mechanisms that regulate the maternal immune system
during pregnancy are complex and not within the scope of this review.
In short, maternal immune regulation is inﬂuenced by genetic, en-
vironmental, paternal and fetal factors, all of which potentially mod-
ulate the maternal immune system and aﬀect the susceptibility for
pregnancy complications. Preparation for a pregnancy already start
before conception including maternal immune changes, with altera-
tions in maternal immune cells in peripheral blood and locally in the
endometrial lining of the uterus during the menstrual cycle (Arruvito
et al., 2007; Kallikourdis and Betz, 2007). In response to the exposure to
fetal antigens via paternal semen further preparation for pregnancy is
achieved (Robertson, 2005; Sharkey et al., 2007). During pregnancy
many (if not all) immune cells are involved in fetal tolerance. It has
been shown that regulatory T (Treg) cells are essential for the induction
of maternal tolerance to fetal tissues, that these Treg are likely fetus
speciﬁc (Tilburgs et al., 2008), and that depletion of Treg cells during
early pregnancy in mice caused higher rates of fetal resorptions and
lower implantation rates. Inadequate numbers and function of Treg
cells are associated with human reproductive disorders as infertility,
miscarriage and preeclampsia (Sasaki et al., 2004; Sasaki et al., 2007;
Guerin et al., 2009). Also other immune cells, as dendritic cells,
(uterine) NK cells, B cells, monocytes, and macrophages are all involved
in fetal tolerance. Especially the latter one, macrophages might be re-
levant in the link between pregnancy and neurodevelopmental com-
plications.
3.2. Possible vulnerability of placental and CNS macrophages for
inﬂammatory stimuli
Diﬀerent subsets of macrophages are known, which have speciﬁc
roles in inﬂammation, infection, tissue remodelling and vascularisation
(Mcgrath et al., 2015; Franken et al., 2016). Macrophages are classiﬁed
by a physiological deﬁnition of macrophage subsets (Murray et al.,
2014), and are implied in many diseases. After an inﬂammatory sti-
mulus, macrophages switch to an inﬂammatory functional subset; al-
though this switching of macrophages has beneﬁcial short term eﬀects,
its long term tissue destructing eﬀects are implicated in many diseases,
as autoimmune diseases, cancer, heart diseases, and metabolic diseases
(Hamidzadeh et al., 2016). During pregnancy, both maternal and fetal
macrophages are important. Mostly, maternal macrophages are de-
cidual and fetal macrophages placental. Maternal macrophages are in-
volved in placental development and have roles in placentation and
vascularisation processes (Svensson-Arvelund and Ernerudh, 2015;
Mori et al., 2016). There is some evidence that the balance of macro-
phage subsets is important for pregnancy success, and that a misbalance
in maternal macrophages is involved in pregnancy complications
(Schonkeren et al., 2011). Whether, this misbalance is caused by an
inﬂammatory stimulus is not known.
Within the fetal brain, the local macrophages, or microglia, are
important for synaptic plasticity by remodelling synaptic connections,
tissue inﬂammation and clearance of debris. Especially, synaptic
pruning is relevant during development and in postnatal life (Paolicelli
et al., 2011; Schafer et al., 2012). Similar to other macrophages, mi-
croglia can be divided into functional subsets according to their phe-
notype (Kigerl et al., 2009), with the more inﬂammatory functional
subset contributing to neurodevelopmental disorders (Hong et al.,
2015; Sekar et al., 2016).
It is very interesting that contrary to other tissue macrophages,
placental (fetal) and CNS macrophages develop from the embryo yolk
sac directly and not through erythro-myeloid progenitors (Adhyatmika
et al., 2015), this could explain the vulnerability of these macrophages
for inﬂammatory stimuli.
3.3. Maternal immune disturbances inﬂuence neuro-immune development
A speciﬁc ﬁeld of fetal immune development is neuro-immunity.
During and after pregnancy, fetal and neonatal immunity is developing.
The development of myeloid cells (macrophages, dendritic cells and
microglia) is between week 4–7 of pregnancy while for lymphoid cells
this is somewhat later: between 8 and 18 weeks of gestation (Vieau
et al., 2007; Marques et al., 2013; Adhyatmika et al., 2015). During
early pregnancy, myeloid progenitors from the primitive yolks sac co-
lonize the neuro-epithelium and diﬀerentiate into microglia, the CNS-
resident immune cells. M-CSF and CSF-1 receptors recruit microglial
cells to the central nervous system (Bilbo and Schwarz, 2012). Micro-
glia are involved in orchestration of synaptic connections, and also have
an immune function, producing cytokines and express immune related
(cytokine) receptors: CD11b, TNF, CCL2, MHC molecules, TLRs, ICAM,
Nestin. They also produce M-CSF, CSF-1, MCP-1, CCL3, CCL6, CCL7,
CX3CR1, CXCL6 (Bilbo and Schwarz, 2012). Microglial cells are espe-
cially important in the hippocampus, a region with extensive neuro-
genesis, which is a critical region for learning, cognition, memory and
behavior. Neuronal migration of new neurons in the brain is further
guided by CXCL 12 and its receptor CXCR4. NCH1 aﬀects activity-de-
pendent synapse formation, while TNF promotes synaptic transforma-
tion (Bilbo and Schwarz, 2012). The complement factors C1q and C3
have a role in synapse pruning by the microglia cells (Hong et al.,
2015).
As it is known that cytokines aﬀect neuronal function (reviewed in
Filiano et al. (2014)), alterations in the maternal immune system most
likely aﬀect neurodevelopment of the fetus. The fetal blood brain bar-
rier (fBBB) might be permissive for these cytokines and even for im-
mune cells coming from the mother and passing the placenta as this
fBBB is not completely functional until late in gestation or early
childhood. This suggests that immune molecules are involved in be-
havioral outcomes, including cognition, mood, and social interactions.
Indeed, there is literature, showing the involvement of diverse immune
challenges during early development in neurodevelopmental and neu-
ropsychiatric disorders (Bilbo and Schwarz, 2012). A well-known ex-
ample of this is the association between maternal infection and autism
in the progeny (Knuesel et al., 2014; Mattei et al., 2017). Disturbances
in early fetal and neonatal neurodevelopment are related to maternal
immune activation (MIA) during pregnancy (as viral and bacterial in-
fection), both of peripheral immune cells and local immune cells in the
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placenta (Estes and Mcallister, 2016). These neurodevelopmental dis-
turbances can be both a consequence of the maternal immune activa-
tion itself, or by the pathogen directly (Estes and Mcallister, 2016).
The sometimes long latent period between the maternal immune
activation and altered neurodevelopmental outcomes is not clear. A
possible pathway could be through epigenetic modiﬁcations of the
microglia, which could have persistent inﬂuence on their phenotype
and with that on their functional development (Nardone and Elliott,
2016). Indeed a recent mouse study has shown alterations in the epi-
genome of microglia after maternal immune activation in a mouse
asthma model (Vogel Ciernia et al., 2018). Another possible long term
pathway might be via maternal microchimeric cells to the fetal brain as
described below.
A possible pathway might be the role of leukemia inhibitory factor
(LIF) in neurodevelopment and inﬂammation. It is known that LIF is
involved in fetal neurogenesis (Simamura et al., 2010). LIF itself is a
cytokine of the IL6 cytokine family and has some roles in inﬂammation
(Yue et al., 2015), but more interestingly it is also blocked by other
cytokines. Interestingly, in a mice model it has been shown that ma-
ternal immune activation causes a reduction in fetal LIF, and this was
associated with decreased fetal neurogenesis (Tsukada et al., 2015).
Early brain development -even up to early adulthood- and in more
detail neurogenesis, is characterized by extensive elimination of sy-
napses, “pruning”, especially in the cerebral cortex. Mechanistically in
these pathways the important role of (CNS) microglia cells is well es-
tablished. As described above microglia cells are key immune cells in
the CNS which have, besides an involvement in immune modulation
and damage sensoring, important functions in brain development pro-
cesses, such as synapse formation and removal of cellular debris in the
CNS (Wu 2016). TAM receptors (tyrosine kinases) such as (Tyro3 in
neurons), Mer and Axl2 (in microglia cells) and the ligands Gas6 and
protein S, are important in these, driving these crucial functions during
neurogenesis (Fourgeaud et al., 2016). Direct evidence for the activa-
tion of fetal microglia after intra-uterine infection has been given by a
recent paper (Mattei et al., 2017; Schaafsma et al., 2017). Pregnant
mice were challenged with LPS, microglia of mice that were exposed to
LPS during embryonic development displayed altered activation
(Schaafsma et al., 2017), with whole brain microglia displaying a per-
sistent reduction in pro-inﬂammatory activation, whereas hippocampal
microglia of these mice displayed an increased inﬂammatory response
to a LPS re-challenge (Schaafsma et al., 2017). Moreover, this paper
showed that this LPS exposure negatively aﬀects learning and behavior
in the oﬀspring.
Although microglia cells are thought to be protected by two sepa-
rate barriers, both the placental and the blood-brain barrier, there are
many examples, as viruses, which are able to cross one or both of these
barriers, some well-known are CMV, Zika virus (ZKV), and Rubella.
In contrast to adults, the fetal blood-brain barrier might be less
functional, leaving fetal brains less protected for e.g. immune cells and
cytokines. In autopsy studies in adults, fetal cells have been found in
maternal brains (Chan et al., 2012; Rijnink et al., 2015), suggesting that
maternal cells can home into the fetal brain, we are however not aware
of maternal cells found in fetal brain tissue. However homing of com-
petent maternal immune cells in fetal tissue, other than fetal brain is
well demonstrated (Aractingi et al., 1998). More in detail; it has been
shown that in mice not before late pregnancy the blood brain barrier is
fully restrictive to for example maternal antibodies, which potentially
could cause fetal brain injury (Kowal et al., 2015). Moreover, a recent
animal study provides evidence that viral infections in itself are suﬃ-
cient to modulate the function of the blood brain barrier in developing
fetuses (Bloise et al., 2017). Moreover, it is known that several cyto-
kines, as well as maternal leukocytes can cross the placental barrier
(Kinder et al., 2017). Therefore, it is reasonable to believe that any
maternal inﬂammatory response, leading to altered cytokine levels and
leukocyte populations will inﬂuence fetal immune cells as well both
having a systemic eﬀect on fetal immune cells and possible local eﬀect
on brain immune cells. Especially maternal cells which are primed by
an infection in a more inﬂammatory phenotype could have fetal con-
sequences. Once crossing the placenta, maternal microchimeric cells,
have been linked to immune development in oﬀspring (reviewed in
Kinder et al. (2017)).
In a mice model it was recently shown that maternal challenge with
LPS (an inﬂammation model) causes altered activation of fetal micro-
glia (Schaafsma et al., 2017). So taken together we postulate that
during maternal infection fetal microglia can be activated either di-
rectly (as by some viruses), or indirectly through cytokines or maternal
microchimeric cells (Kinder et al., 2017).
Both prenatal and postnatal inﬂuence on the function of microglia
cells might be crucial to these developments, whereby microglia sur-
veillance and thereby immune related pathways probably have im-
portant eﬀects on synaptic function and plasticity. Acute interference
with e.g. the CX3CR1- CX3CL1 pathway will stimulate microglia cells
and reduces neuronal activity, while chronic reduction of the CX3CR1-
CX3CL1 pathway leads to an increase in IL1 in the CNS (associated with
an increase in long-term potentiation (LTP)). Also, TNF can modify
synaptic strengths having opposite eﬀects, depending on the brain re-
gion (e.g. the hippocampus and the stratum behave diﬀerently).
Increase in TNF (and of TLR2 or TLR4) -and a decrease in CD200- (a
more inﬂammatory phenotype) is associated with decreased LTP.
Microglia cells that transiently express DAP12 also determine replace-
ment during early development of NMDA receptor subunits.
The combined inﬂuence of prenatal and postnatal inﬂuence on
microglia cell function has been further elaborated by the two-hit
theory (Estes and Mcallister, 2016). Possibly maternal immune activa-
tion increases the susceptibility for later in life neurodevelopmental
disorders (Estes and Mcallister, 2016), with a second post natal event
leading to the disorder. This has been show to be involved in schizo-
phrenia in a recent study, which showed that prenatal infection and
psychological trauma in peripubertal life can act in synergy to increase
the risk of schizophrenia (Debost et al., 2017).
The recent ZIKA virus (ZKV) outbreak underscored the devastating
eﬀects of a virus infection during pregnancy on neurodevelopment
(Petersen et al., 2016). The worldwide presence (urban or peri-urban
cycle) of Aedes as a vector makes that the disease can be spread
worldwide relatively rapidly (Musso, 2015). Besides diﬀuse astroglyosis
and activated microglia cells (and macrophages), clusters of viral like
particles, morphologically consistent with characteristics of the Flavi-
viridae virus family, were demonstrated using electron microscopy
(Mlakar et al., 2016). There is strong neurotropism (neuroinvasiveness
and neurovirulence) as no virus was detected in other organs. The viral
persistence in the brain might be because of an immunological “secure”
milieu for the virus. Human embryonic neuronal progenitor cells
(hNPCs) are a direct target of ZKV infection. Moreover, it has been
shown that ZKV itself has an eﬀect on microglia cells (Nowakowski
et al., 2016; Lum et al., 2017; Meertens et al., 2017). In neurospheres
and brain organoid models for ﬁrst trimester brain development, a re-
duction in the growth rate and viability (30% reduction) of human
brain cells was found, explaining stunted NPC growth after ZKV in-
fection resulting e.g. in microcephaly (Garcez et al., 2016). Most im-
portant is that microcephaly might be the tip of the iceberg with pos-
sible other less severe complications aﬀecting the (fetal/neonatal) brain
development, having important eﬀects on e.g. cognitive function. Since
a direct eﬀect of ZKV on microglia has been found, in case of ZKV both
the eﬀect of ZKV itself as well as possibly the maternal immune acti-
vation could cause the disturbances in neurodevelopment.
3.4. Immune based complications of pregnancy, as preeclampsia, and
neurodevelopment
The maternal immune system is involved in several complications of
pregnancy as preterm birth, fetal growth restriction and preeclampsia.
Interestingly, especially the latter one, preeclampsia, has been linked to
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neurodevelopmental problems as neurodevelopmental delay and
autism (Whitehouse et al., 2012; Walker et al., 2015; Warshafsky et al.,
2016). The mechanisms between this correlation have not been clar-
iﬁed yet. However, it is tempting to speculate that the inﬂammatory
immune response as seen in preeclamptic women have similar con-
sequences on microglia as maternal immune activation as described
above, and with that inﬂuence fetal microglia stability. Especially since
an inﬂammatory response during pregnancy has been linked to altered
microglia function (Schaafsma et al., 2017). Indirect evidence for the
relation between preeclampsia and microglia fetal alteration comes
from a rat study (Johnson et al., 2014). In this study a rat model was
used combing the reduced uteroplacental perfusion pressure model of
placental ischemia with a high cholesterol diet (Johnson et al., 2014).
Although this study showed more activation of maternal microglia
compared to control pregnant rats (Johnson et al., 2014), no data on
fetal microglia was shown. This eﬀect is preeclampsia speciﬁc and not
pregnancy related, as an earlier study showed no eﬀect from pregnancy
itself on microglia activation (Johnson et al., 2015).
As preeclampsia is often accompanied by fetal growth restriction,
and also (iatrogenic) preterm birth, it is diﬃcult to fully clarify the
pathways. Interestingly, any disturbance of fetal neurodevelopment due
to preeclampsia could even further dysregulated by breastfeeding as, as
studies have shown that women with preeclampsia have altered levels
of milk neurotrophins, which have a role in neurodevelopment (Dangat
et al., 2013). This is however hypothetical, and is (most possibly) by far
outreached by the beneﬁcial eﬀect of breastfeeding.
4. Conclusions
During pregnancy, fetal neurodevelopment is vulnerable for any
disturbances, most possibly also for disturbances of the maternal im-
mune regulation and environmental pertubations,disrupting fetal neu-
rodevelopment. The recent outbreak of ZKV and its consequences on
fetal neurodevelopment shows the devastating eﬀects of an environ-
mental inﬂuence -such as a viral infection- during pregnancy -most
possibly via an eﬀect on fetal immune development- can have. A pos-
sible link between both pregnancy complications and disturbed neu-
rodevelopment could be caused by perturbed function of placental and
CNS macrophages (microglia) (Fig. 1). However, more research is
needed to delineate the causal underpinnings of neurodevelopmental
disorders and neuroinﬂammation during fetal development.
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